CJC-1295 + Ipamorelin
GHRH-analog plus selective secretagogue blend for endocrine signaling research.
Intended use: Laboratory research and analytical purposes only. This material is not a drug, not a dietary supplement, not a cosmetic for consumer use, and not for administration to humans or animals.
Selected: 5mg/5mg · Single vial
Research chemicals only. By adding to cart you reaffirm laboratory / analytical use—not for human or animal use.
| Product type | Research chemical |
|---|---|
| CAS | Blend |
| Molecular formula | Blend |
| Molecular weight | N/A |
| Purity (typical) | ≥98% each component |
| Form | Lyophilized blend |
| Intended use | Laboratory research & analytical use only |
| Not for | Human or animal use; clinical, dietary, or household use |
CJC-1295 + Ipamorelin overview
CJC-1295 (without DAC in standard lots unless noted) combined with Ipamorelin is used to study complementary GHRH- and ghrelin-receptor pathway activity in controlled endocrine models.
Background
GHRH analogs and ghrelin mimetics were developed on parallel tracks; co-administration designs later became common in laboratory protocols exploring somatotroph axis kinetics.
Research focus areas
Investigators commonly examine CJC-1295 + Ipamorelin across the following experimental themes:
Storage (laboratory handling)
Store lyophilized research material frozen, dry, and protected from light unless the lot COA specifies otherwise. Any reconstitution or experimental protocol must follow your institution’s laboratory SOPs for research chemicals. AminosPure does not provide instructions for human or animal administration and does not sell products for those uses.